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 Informed Consent is a process 
 Process is important in the initial obtaining consent, 
but it is not limited to having the subject sign the 
document. 
 Consent is an ongoing process that lasts the entire 
time of the subjects participation in the study 
 The obligation to obtain consent flows from the 
ethical principle of  “Respect for Persons”. 
 People have a fundamental right not to be used 
for research without their express permission. 
 This includes not having their private 
information used without their knowledge and 
permission. 
 When people are hospitalized, they have a 
reasonable expectation of privacy. 
 In performing human experimentation, we are 
not only allowing, but often facilitating, people 
placing themselves in harms way. 
 We allow people to accept this risk only if they 
are adequately informed. 
 The consent document is only one part of this, 
but it is an essential written statement of all the 
information that the subject needs to know to 
make an informed choice. 
 
 Obtaining Consent: 
 Is much more than having the subject sign the paper. 
 In obtaining consent, there must be a discussion 
between the investigator and the subject.  If it is 
delegated to another individual, they must be fully 
trained and aware of all aspects of the study, and the 
PI must be available to answer questions if needed. 
 Consent must be obtained under circumstances that 
allow the subject to fully consider whether they wish 
to participate, without time pressure or coercion. 
 The obligation to inform the subject does not 
end after he or she signs the consent document. 
 It is expected that throughout the study the 
investigator will be communicating with the 
subject, soliciting questions, facilitating the 
ability of the subject to report any potential 
adverse reactions or other relevant information. 
 The consent document is the only written 
record we have that says exactly what it is that 
you will tell the subject. 
 It must contain all information that a 
reasonable person needs, and that would be 
expected to want to know to decide whether or 
not to participate in the study, in a way that is 
understandable. 
 It must contain information that addresses 
specific regulatory requirements. 
 A statement that this is research, why you are doing 
the study, what the subject will have to do to 
participate 
 What is the potential for harm in participating in the 
study (risk) 
 Is there a prospect for benefit, individually to the 
subject or to society? 
 Are there alternatives to participation (usual care)? 
 How will you protect privacy and confidentiality? 
 Is there compensation, and what you will do if there is 
a research related injury. 
 Who to go to for questions and help 
 That participation is voluntary, and there is no penalty 
for not participating. 
 
 The consent process is a critical element of 
good human subjects research. 
 Consent is an ongoing process that starts with 
the document, and lasts the length of the 
research 
 Give a copy of the SIGNED consent document 
to the subject, and keep the original.  Loss of 
consent document may be interpreted as no 
consent obtained, and may mean you lose that 
subjects data. 
 
 Eligibility criteria define your study population 
 They should be: 
 Clear 
 Well defined 
 Consistent 
 Can I enroll a subject that does not meet my 
criteria, if I think they would be a good 
candidate and there is no increased risk to 
them? 
 When you get IRB approval, you are approved 
to enroll only subjects that meet the criteria you 
specified in your application. 
 If you want to enroll a subject that does not 
meet the criteria, you must ask the IRB first. 
 If you enroll first, and then ask, you will likely 
be considered to be non-compliant. 
 You may not be allowed to use data obtained 
from that subject, therefore you will have 
unnecessarily exposed them to risk. 
 Continued violations may be considered 
serious noncompliance, which must be 
reported to OHRP. 
